Stellaromics Adds Stacie Weninger and Steve McPhail to Board of Directors

February 11, 2026
Stellaromics has appointed industry veterans Stacie Weninger and Steve McPhail to its Board of Directors as it expands its Pyxa 3D spatial multi-omics technology.
Stellaromics Adds Stacie Weninger and Steve McPhail to Board of Directors

Stellaromics has appointed Stacie Weninger, PhD, and Steve McPhail to its Board of Directors, announced in a press release. The company said the appointments come as it scales its Pyxa technology and expands within the life sciences sector.

Dr. Weninger brings over two decades of experience in neuroscience and venture capital, while McPhail has more than 30 years of leadership in genomics and diagnostics. Their combined expertise is expected to support Stellaromics in advancing its spatial analysis tools for researchers and drug developers worldwide.

CEO Todd Dickinson welcomed the new board members, noting their backgrounds will help guide the company’s continued growth and technology expansion.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more